Print this page    •   Back to Web version of article

U.S. News
OraSure HIV Test Inches Closer to FDA Approval

November 29, 2010

The Food and Drug Administration is in the final stages of reviewing a proposed over-the-counter version of the rapid HIV test available in hospitals and clinics, test-maker OraSure Technologies said recently. To gain approval, OraSure will at a minimum have to prove that consumers untrained in lab testing can correctly use the OraQuick Rapid HIV test. The final review includes an assessment of such unsupervised self-testing. OraSure said it expects the trial "will continue well into 2011." "We are extremely pleased to have approval to begin the final phase of studies to support our efforts to obtain FDA approval for an over-the-counter offering of our OraQuick HIV test," said Douglas A. Michels, the company's president and CEO.

Back to other news for November 2010

Excerpted from:
Morning Call (Allentown, PA)
11.23.2010; Spencer Soper

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.